Stay updated on Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6. This indicates a minor patch to the page's metadata or formatting rather than changes to study content or user-facing features.
    Difference
    0.1%
    Check dated 2026-08-29T23:55:18.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The revision label on the page was updated from v3.6.4 to v3.6.5. This indicates a behind-the-scenes update to the site without changing the displayed study information.
    Difference
    0.1%
    Check dated 2026-08-08T18:26:41.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.4, reflecting a software update. No clinical content or trial details were changed.
    Difference
    0.1%
    Check dated 2026-07-25T10:22:43.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    A new page revision tag (v3.6.3) has been added, replacing the previous v3.6.2 to indicate a recent content update.
    Difference
    0.1%
    Check dated 2026-07-03T22:47:02.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.0 to v3.6.2, indicating a deployment patch. This appears to be an internal update and does not reflect changes to study data or user-facing content.
    Difference
    0.1%
    Check dated 2026-06-26T19:41:28.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    The study page now clearly indicates that it is no longer looking for participants, clarifying that recruitment has ceased. In addition, labels for the Intervention/Treatment section were updated to remove spacing around the slash and a site revision note (v3.6.0) was added.
    Difference
    0.4%
    Check dated 2026-06-12T12:25:38.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Early NK/T-cell Lymphoma Clinical Trial page.